Skip to main content
Caplight Logo









HBM Partners

HBM Partners

Overview

HBM Partners is a globally active, Swiss-based, healthcare-focused investment advisor with over USD 2.1 billion in assets under management. The firm focuses on venture, growth and buy-out financings of private companies as well as investments in public companies in the biopharma, medtech, diagnostics and healthcare sectors in Europe and North America as well as in India, China and other Emerging Markets. HBM Partners advises SIX-listed HBM Healthcare Investments Ltd and several specialised public and private equity investment funds.

Year Founded

2001

AUM

$2.1B

Portfolio Companies

9

Investments

HBM Partners investments
CompanyDateStageLead
Numab TherapeuticsMay 2021Series CLead
Nuance PharmaJun 2018Series BCo-investor
GenalyteJan 2021VC RoundCo-investor
R3 Vascular Inc.Oct 2020Series ACo-investor
PerfuzeFeb 2022Series ACo-investor
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Chandra P. Leo

Partner

Priyanka Belawat

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is HBM Partners based?

HBM Partners is headquartered in Zug, Zug, Switzerland.

When was HBM Partners founded?

HBM Partners was founded in 2001.

How many portfolio companies does HBM Partners have?

HBM Partners has 9 portfolio companies in Caplight's dataset.

What are some companies in HBM Partners's portfolio?

Portfolio companies visible on Caplight include Numab Therapeutics, Nuance Pharma, Genalyte, R3 Vascular Inc., Perfuze.

What was HBM Partners's most recent investment shown here?

HBM Partners's most recent investment in this portfolio sample was in Perfuze in 2022.

What sectors does HBM Partners focus on?

HBM Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does HBM Partners focus on?

HBM Partners typically invests at the Mid stage.

What is HBM Partners's AUM?

HBM Partners's assets under management are estimated between $1.0B and $10.0B.

Firmographic Details

HeadquartersZug, Zug
Year Founded2001
AUM$2.1B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?